Health/Biotech
-
Neuralstem: Update On ALS Trial Could Be A Catalyst For The Stock
-
Heart Rhythm Society Announces Dr. Hugh Calkins as the Organization's 35th President
-
Synthetic Biologics Reports First Quarter 2013 Financial Results
-
EntreMed Reports First Quarter 2013 Financial Results
-
University of Maryland Center Appoints Dr. William Rollow as Director of Clincal Services
-
RegeneRx Issues Letter to Sharholders
-
CareFirst Names John Michael O'Brien Vice President of Public Policy
-
Neuralstem Provides Business Update
-
Cytomedix Reports First Quarter 2013 Financial Results
-
Celsion's Q1 Call: What You Need To Know
-
Sucampo's Stock Could Reach $12, Says Maxim's Senior Vice President
-
Futurecare Health And Management Corp. Appoints John Spadaro COO
-
Medifast Reports First Quarter 2013 Results
-
Medifast Management Discusses Q1 2013 Results - Earnings Call Transcript
-
PharmAthene Management Discusses Q1 2013 Results - Earnings Call Transcript
-
Colleen Hordesky, RN, Named Carroll Hospital Center May Associate of the Month
-
Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials
-
Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials
-
Saint Agnes Hospital Appoints Anne Buening Vice President of Mission Integration
-
Aetna Completes Acquisition of Coventry Health Care
